Everolimus Uses

• Advanced breast cancer
• Advanced renal cell carcinoma
• Advanced pancreatic neuroendocrine tumours
• Treatment of subependymal giant cell astrocytoma

How Enzalutamide work Everomus 0.25mg tablet inhibits the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein and helps to reduce the size of tumours and improve outcomes in patients. Common side effects of Enzalutamide Difficulty breathing, or swallowing, swelling of face, lips, tongue, throat, Severe itching, red rash, raised bumps, Infection (chills, increased temperature), Coughing, Wheezing, Excessive thirst, High urine output or severely decreased urine output, Tiredness, Bleeding, Increased appetite with weight loss Disclaimer The content on this website is only for informational purposes. Please take advice from your doctor or healthcare professionals. Do not self-medicate. Consult with your doctor before taking this medicine.